J1710 Injection, hydrocortisone sodium phosphate, up to 50 mg

Short descriptor: Hydrocortisone sodium ph inj

⚠ Terminated HCPCS Level II 2026
Terminated Code
J1710 was terminated as of 2025-12-31 and should not be reported for dates of service after that date. This page is retained for historical reference.
Open J1710 in the app →

Look up J1710 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J1710 is the HCPCS Level II code for Injection, hydrocortisone sodium phosphate, up to 50 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2026-01-01
Termination Date
2025-12-31
2026 Maintenance
Discontinued

Drug Details

Drug / Substance
hydrocortisone sodium phosphate
Dose / Unit
up to 50 mg
Route
Injection

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J1710 with the canonical source and edition:

J1710 — Injection, hydrocortisone sodium phosphate, up to 50 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J1710

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J1710

Related Codes in Section J

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial